Evidence map›Paper›PMID 28342168›Full record

SynthesisJournal of autism and developmental disorders2017

Bone Mass in Boys with Autism Spectrum Disorder.

Chadi A Calarge, Janet A Schlechte

Open access · greenAbstract readMeta-Analysis
In one paragraph

Synthesis in Journal of autism and developmental disorders, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Bone health in children and youth with ASD: a systematic review and meta-analysis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2021
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Altered Bone Status in Rett Syndrome.Life (Basel, Switzerland) · 2021
    Review
  6. Article
  7. Review
  8. Article
  9. Observational
  10. Review
  11. CHRNA7 Deletions are Enriched in Risperidone-Treated Children and Adolescents.Journal of child and adolescent psychopharmacology · 2017
    Observational
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Chadi A CalargeMenninger Department of Psychiatry and Behavioral Science and Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, 1102 Bates Ave, Suite 790, Houston, TX, 77030, USA. chadi.calarge@bcm.edu.ORCID 0000-0002-4368-1294
Janet A SchlechteDepartment of Internal Medicine, The University of Iowa Carver College of Medicine, Iowa City, 52242, IA, USA.
Baylor College of Medicine · USUniversity of Iowa · US

Funding

UNIVERSITY OF IOWA CTSA FOR PEDIATRIC RESEARCHUL1RR024979 · NCRR · UNIVERSITY OF IOWA · PI ROSENTHAL, GARY E · 2007 to 2011
$31.8M
Counteracting Risperidone-Induced Hyperprolactinemia in YouthsK23MH085005 · NIMH · UNIVERSITY OF IOWA · PI CALARGE, CHADI A. · 2009 to 2013
$866k
Long-Term Safety and Genetic Risk Factors of Risperdone Treatment in YouthR21MH080968 · NIMH · UNIVERSITY OF IOWA · PI CALARGE, CHADI A. · 2008 to 2010
$400k
NCRR NIH HHS UL1 RR024979NIMH NIH HHS K23 MH085005NIMH NIH HHS R21 MH080968
6 · The paper itself

Abstract

To examine bone mass in children and adolescents with autism spectrum disorders (ASD). Risperidone-treated 5 to 17 year-old males underwent anthropometric and bone measurements, using dual-energy X-ray absorptiometry and peripheral quantitative computed tomography. Multivariable linear regression analysis models examined whether skeletal outcomes differed among participants with (n = 30) versus without ASD (n = 156). After adjusting for potential covariates, having ASD was associated with significantly lower trabecular bone mineral density and bone strength at the radius, and with marginally lower total body less head bone mineral content (p < 0.09). No differences at the lumbar spine were observed. ASD are associated with lower bone mass. Future studies should investigate interventions to optimize skeletal health in ASD.

Indexed as

Autism Spectrum DisorderBone DensityAbsorptiometry, PhotonAdolescentAntipsychotic AgentsChildChild, PreschoolCross-Sectional StudiesHumansLumbar VertebraeMaleObservational Studies as TopicRandomized Controlled Trials as TopicRisperidoneTomography, X-Ray ComputedAntipsychotic AgentsRisperidoneAutismBone massRisperidone

Identifiers

PMID28342168
PMCPMC6727659
OpenAlexW2603252343

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.